Vinge has advised Xspray Pharma, a pharmaceutical company with several product candidates in clinical development listed on Nasdaq Stockholm, in connection with a share issue whereby the company raises proceeds of approximately SEK 100 million.
Vinge’s team consisted of Dain Hård Nevonen, Linnéa Sellström and Joel Magnusson.
